The COVID-19 Crisis impact on the Demand of High-Performance Medical Plastics- Exclusive Report by MarketsandMarkets™

The report "High Performance Medical Plastics Market by Type (FP, HPPA, PAEK, PPS, PEI), Application (Medical Supplies, Medical Equipment & Tools, Drug Delivery, Prosthesis & Implants, Therapeutic System), Region - Global Forecast to 2026", size is projected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period 2021 to 2026. Increasing use of high performance medical plastics in advanced medical technology in implants, precision medicines, smart inhalers, artificial organs, customized minimally invasive devices, and robotic assistance in surgical operations are propelling the demand for high performance medical plastics across the globe.

North America accounted for the largest share of the high performance medical plastics market in 2020. The countries countries considered for the study in North America are the US, Canada, and Mexico. High performance medical plastics are used in the manufacturing of medical devices and equipment employed in the healthcare industry for surgical and procedural applications. The medical devices market in North America is highly diversified and offers a variety of products to diagnose and treat patients, ranging from medical catheters to vascular grafts and implants. Companies in North America mainly focus on the development of high-quality products using advanced technology, which mandates significant investment in R&D. New innovations, such as neuro-stimulators, stent technologies, biomarkers, robotic assistance, and implantable electronic devices in the medical device market in North America, are leading to the overall growth of the healthcare industry. The demand for high performance medical plastics is expected to increase rapidly in this region in certain application areas, such as orthopedics, medical instruments, and implants.

Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastics (France), Celanese Corporation (US), Trelleborg (Swed
read more..